Purchase Order 75N98026P00779
Award Date 8/1/26
Potential Completion Date 7/31/27
Potential Value $21K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>
- <p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>
- <p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>
- <p>The National Human Genome Research Institute issued a $98,905.32 delivery order to Illumina, Inc. on August 22, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>
- <p>The National Human Genome Research Institute issued a $15,321.60 delivery order to Illumina, Inc. on July 18, 2019, for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used for this award.</p>
- <p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences of California, Inc. on October 8, 2020, with a ceiling value of $23,531.00 to perform high-throughput, large-scale DNA sequencing and sequence analysis. Work is performed in Menlo Park, California. The order carries firm fixed-price pricing and has an ultimate completion date of December 8, 2020.</p>
- <p>The National Human Genome Research Institute issued a $5,450.23 delivery order to Illumina, Inc. on August 15, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure and an ultimate completion date of September 14, 2018.</p>
- <p>The National Human Genome Research Institute issued a $30,051.65 delivery order to Illumina, Inc. on May 6, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price, and no set-aside was used.</p>
- <p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on March 27, 2018, with a ceiling value of $19,253.76 for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed price and was not issued under a set-aside. Ultimate completion date is September 2, 2020.</p>
- <p>The National Human Genome Research Institute issued a $13,029.68 delivery order to Illumina, Inc. on September 12, 2017, for genetic sequencing and genomic analysis equipment and supplies.</p> <p>Place of performance is North Bethesda, Maryland. The order has a firm fixed-price structure and an ultimate completion date of October 11, 2017. No set-aside was used.</p>